Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.
作者信息
Fung J, Todo S, Abu-Elmagd K, Jain A, Tzakis A, Martin M, Selby R, Bronsther O, Doyle H, Gayowski T
机构信息
Pittsburgh Transplantation Institute, University of Pittsburgh School of Medicine, Pennsylvania.
出版信息
Transplant Proc. 1993 Feb;25(1 Pt 2):1130.
Abstract
摘要
相似文献
1
Randomized trial in primary liver transplantation under immunosuppression with FK 506 or cyclosporine.
Transplant Proc. 1993 Feb;25(1 Pt 2):1130.
2
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.一项关于在免疫抑制下使用FK 506与环孢素进行原位肝移植的随机试验。
Transplant Proc. 1991 Dec;23(6):2977-83.
3
The superior immunosuppressant according to diagnosis: FK 506 or cyclosporine A.根据诊断结果使用的最佳免疫抑制剂：FK506或环孢素A。
Transplant Proc. 1995 Feb;27(1):1117-20.
4
[Comparison between tacrolimus (FK 506) and cyclosporin in immunosuppressive therapy after liver transplantation].[肝移植后免疫抑制治疗中他克莫司（FK 506）与环孢素的比较]
Z Gastroenterol. 1995 Oct;33(10):624-5.
5
Rejection: FK 506 for rescue or maintenance.排斥反应：使用FK 506进行挽救或维持治疗。
Transplant Proc. 1993 Apr;25(2):1914-5.
6
FK 506 versus cyclosporine in pediatric liver transplantation.儿童肝移植中FK506与环孢素的比较
Transplant Proc. 1991 Dec;23(6):3010-5.
7
A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation.他克莫司（FK 506）与环孢素在肝移植免疫抑制中的比较。
N Engl J Med. 1994 Oct 27;331(17):1110-5. doi: 10.1056/NEJM199410273311702.
8
Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.肝移植后霉酚酸酯与环孢素微乳剂或他克莫司前瞻性随机试验的四年随访
Clin Transplant. 2004 Aug;18(4):463-72. doi: 10.1111/j.1399-0012.2004.00192.x.
9
Long-term comparison of tacrolimus versus cyclosporine in liver transplantation. The US FK Study Group.他克莫司与环孢素在肝移植中的长期比较。美国FK研究小组。
Transplant Proc. 1998 Jun;30(4):1399-400. doi: 10.1016/s0041-1345(98)00288-7.
引用本文的文献
1
Maintenance immunosuppression for adults undergoing liver transplantation: a network meta-analysis.肝移植成年受者的维持性免疫抑制：一项网状Meta分析。
Cochrane Database Syst Rev. 2017 Mar 31;3(3):CD011639. doi: 10.1002/14651858.CD011639.pub2.
2
What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.关于在他克莫司免疫抑制下进行的原位肝移植，我们了解到了什么？对首批1000例患者的长期随访。
Ann Surg. 1999 Sep;230(3):441-8; discussion 448-9. doi: 10.1097/00000658-199909000-00016.
3
FK506 in solid organ transplantation.实体器官移植中的FK506
Ther Drug Monit. 1995 Dec;17(6):592-5. doi: 10.1097/00007691-199512000-00008.
4
5
A risk-benefit assessment of tacrolimus in transplantation.他克莫司在移植中的风险效益评估。
Drug Saf. 1995 May;12(5):348-57. doi: 10.2165/00002018-199512050-00006.
6
Single-center experience with primary orthotopic liver transplantation with FK 506 immunosuppression.FK506免疫抑制下原位肝移植的单中心经验。
Ann Surg. 1994 Sep;220(3):297-308; discussion 308-9. doi: 10.1097/00000658-199409000-00006.
本文引用的文献
1
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine.一项关于在免疫抑制下使用FK 506与环孢素进行原位肝移植的随机试验。
Transplant Proc. 1991 Dec;23(6):2977-83.
2
Early trials with FK 506 as primary treatment in liver transplantation.FK506作为肝移植主要治疗手段的早期试验。
Transplant Proc. 1990 Feb;22(1):13-6.
Zotero 插件